Netherlands· NL-1758f3ed9a71
Ciprinol 750 mg, filmomhulde tabletten
A ciprofloxacin product containing ciprofloxacinehydrochloride 1-water, registered in Netherlands by Krka d.d., Novo mesto. The same ATC class is registered in 17 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Ciprofloxacin is registered in 17 of 19 countries.
Countries holding a registration under ATC J01MA02 (ciprofloxacin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 10 of them publish a price we can compare per daily dose
Ciprofloxacin · ATC J01MA02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ciprofloxacin costs, country by country.
Normalised to the WHO defined daily dose (1 g), the median price runs from $2.33 in Italy to $6.51 in Switzerland — a ×2.8 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ciprofloxacin · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$6.51
- IT Italy$2.33
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- CIPROFLOXACINEHYDROCHLORIDE 1-WATER
- Manufacturer
- Krka d.d., Novo mesto
- Country
- Netherlands (NL)
- ATC code
- J01MA02
- ATC class
- Ciprofloxacin
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id32446
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
616 interactions on record for ciprofloxacin.
Graded by severity as the source publishes them — 110 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ciprofloxacin · interactions on record
616 records
- 110 severe
- 266 moderate
- 61 minor
- 139 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NaloxegolA06AH03severe
40 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01MA02
Ciprofloxacin, as other registers publish it.
- CanadaACT CIPROFLOXACINTEVA CANADA LIMITED
- CanadaACT CIPROFLOXACINTEVA CANADA LIMITED
- CanadaACT CIPROFLOXACINTEVA CANADA LIMITED
- CanadaAURO-CIPROFLOXACINAURO PHARMA INC
- CanadaAURO-CIPROFLOXACINAURO PHARMA INC
- SwitzerlandBactiflox 500, FilmtablettenAcino Pharma AG
- SwitzerlandBactiflox 500, FilmtablettenAcino Pharma AG
- SwitzerlandBactiflox 500, FilmtablettenAcino Pharma AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9d04a0da-13e9-422f-b31a-9289a3c7967c GET /v1/drugs/9d04a0da-13e9-422f-b31a-9289a3c7967c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h32446_smpc.pdf",
"strength": null,
"atc_label": "Ciprofloxacin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg32446",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CROSCARMELLOSE NATRIUM (E 468)",
"HYPROMELLOSE (E 464)",
"MAGNESIUMSTEARAAT (E 470b)",
"NATRIUMZETMEELGLYCOLAAT",
"POVIDON (E 1201)",
"PROPYLEENGLYCOL (E 1520)",
"SILICIUMDIOXIDE (E 551)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"CIPROFLOXACINEHYDROCHLORIDE 1-WATER"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h32446.pdf",
"authorised_at": "2005/05/18",
"procedure_number": "NL/H/0857/003",
"dispensing_status": "Uitsluitend recept",
"registration_number": "32446",
"additional_monitoring": "N"
}See everything about ciprofloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.